If heart disease effects ethnicities differently, does the FDA -- the Food and Drug Administration -- encourage drug companies to present data across all of the demographic groups?
Dr. Paul Underwood:
Yes, the FDA is strongly considering or encouraging drug companies to present data as it relates to different genders, men and women, ethnicities and age as well. And so there is a strong push by the FDA to make sure that the studies that are done can be generalized over wide population ranges. So that if medicine is approved than it may be useful for Asians as well, so we have to know the effectiveness of the agent in that group as well as any potential side effects because sometimes side effects are more common in certain groups than other groups. An example is with the angiotensin-converting enzyme inhibitors, which are remarkable medications, which protect the kidneys, protect the blood vessels, protect the heart and can actually reduce stroke.